Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133878) titled 'Study on the Effects of Choline Alfoscerate Combined with Phosphatidylserine Intervention on Improving Daytime Cognitive Function, Sleep, and Mood' on Oct. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Condition:
Subjective cognitive decline or mild cognitive impairment
Intervention:
Group B:Placebo
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-13
Target Sample Size: Group B:40;Group A:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sh...